from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0308/-

LFCtreatmentdescriptionclass of inhibitor

-0.989

Amikacinug/mL Amikacintranslation

0.227

Cap5-10ug/mL Capreomycintranslation

-0.999

Rox10-50 ug/mL Roxithromycintranslation

0.732

SM2-5 ug/mL Streptomycintranslation

-0.501

Tet5-10 ug/mL Tetracyclinetranslation

-0.276

Rif0.2-5ug/mL Rifampicintranscription

-0.441

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.628

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.114

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.451

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.531

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.022

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.453

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.351

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.656

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.651

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.787

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.680

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.550

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.566

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.097

KCN5-20 ug/mL Potassium cyaniderespiration

0.109

NaN30.2-2 mM Sodium aziderespiration

0.150

Nigericin50 uM Nigericinrespiration

-0.027

TRC10-150 ug/mL Triclosanrespiration

-1.428

TRZ10-25 ug/mL Thioridazinerespiration

-1.686

Valinomycin0.5-10 uM Valinomycinrespiration

-0.166

ZnSO42 mM ZnSO4respiration

0.880

menadione6-10 ug/mL Menadionerespiration

-0.357

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.156

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.339

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.429

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.647

NRP_1Non-replicating persistence stage 1dosRassociated

0.189

Amp0.2mg/mL AmpicillincellWall

0.380

Cephalexin20-100 ug/mL CephalexincellWall

0.542

Cerulenin0.32-5 ug/mL CerulenincellWall

0.581

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.220

EMB10-20 ug/mL EthambutolcellWall

-0.099

Eta12-40 ug/mL EthionamidecellWall

0.488

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.239

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.080

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.236

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.166

BZA0.12 mg/mL BenzamidearomaticAmides

1.294

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.519

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.203

H2O24 mM hydrogen peroxideDNAdamaging

0.543

Levo10 ug/mL LevofloxacinDNAdamaging

1.026

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.484

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.565

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.103

UVUV-irradiationDNAdamaging

0.011

ARP41-4 ug/mL Antitubercular compound ARP4?

0.752

Antimycin12.5-50 ug/mL Antimycin A?

0.025

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.143

PA_110-50 ug/mL Antitubercular compound PA-1?

0.620

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.663

PA8240.2-2 ug/mL PA-824?

-0.398

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.387

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.693

Verapamil50 uM Verapamil?

0.135

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.979

methoxatin10-20 ug/mL Methoxatin?